CIMARa
Consortium for Intracarnial Metastasis Academic Research
Consortium for Intracarnial Metastasis Academic Research
The CIMARa Consortium, formalized in June 2021, includes a group of Clinical Investigators and Research Scientists who share the collective goal of improving outcomes for patients with central nervous system (CNS) metastases through the awareness and coordination of multi-institutional clinical trials testing novel therapeutic agents for this unique patient population.
To establish an international infrastructure to enhance discovery and development of CNS metastasis therapies.
To provide a network of investigators who understand and are willing to advance and implement multi-center clinical trial opportunities for patients living with CNS metastases.
To develop opportunities that harmonize clinical trial end-points regarding CNS metastases outcomes.
To provide a common web-based forum for patients and providers to learn about clinical trial opportunities for CNS metastases.
CIMARa TEAM in TORONTO 8/22 at SNO/ASCO Brain Mets Conference